RecruitingPhase 1NCT06809400
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Sponsor: Eli Lilly and Company
Maitland, FL · Naples, FL · Orlando, FL · +9 more sites
Parkinson's Disease clinical trials in Orlando, FL
11 recruiting parkinson's disease studies with a site in Orlando, FL.
RecruitingPhase 3NCT06312176
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor: Merck Sharp & Dohme LLC
Altamonte Springs, FL · Gainesville, FL · Orlando, FL · +43 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Altamonte Springs, FL · Orlando, FL · West Palm Beach, FL · +36 more sites
RecruitingPhase 3NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Sponsor: Merck Sharp & Dohme LLC
Fort Myers, FL · Gainesville, FL · Miami Beach, FL · +50 more sites
RecruitingPhase 3NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Sponsor: AstraZeneca
Fort Myers, FL · Miami, FL · Miami Beach, FL · +60 more sites
RecruitingPhase not listedNCT07428447
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Sponsor: CND Life Sciences
Orlando, FL · +7 more sites
RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Atlantis, FL · Boca Raton, FL · Lady Lake, FL · +50 more sites
RecruitingPhase 2NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Sponsor: Appello Pharmaceuticals, Inc.
Boca Raton, FL · Hallandale, FL · +27 more sites
RecruitingPhase 2NCT06680830
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Sponsor: Neuron23 Inc.
Boca Raton, FL · Gainesville, FL · Orlando, FL · +42 more sites
RecruitingPhase not listedNCT07330258
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Sponsor: Bayer
Miami, FL · Orlando, FL · Tampa, FL · +24 more sites
RecruitingPhase 4NCT06765668
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Sponsor: Impax Laboratories, LLC
Aventura, FL · Boca Raton, FL · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.